Mutation analysis of hematopoietic cell phosphatase gene in acute leukemia / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 128-132, 2004.
Article
in En
| WPRIM
| ID: wpr-278783
Responsible library:
WPRO
ABSTRACT
The hematopoietic cell phosphatase (HCP or SHP-1), the SH2 domain contain protein tyrosine phosphatase, is a crucial negative regulator in the process of hematopoietic cell development, proliferation and receptor-mediated mitogenic signaling pathways, and its mutation is responsible for the over-expansion and inappropriate activation of myelomonocytic population in motheaten mice. The aim of the study was to evaluate the role of the HCP gene in leukemogenesis. Bone marrow and/or peripheral blood from 32 acute myeloid leukemia (AML) patients, 9 acute lymphocytic leukemia (ALL) patients, 8 leukemia cell lines and 50 normal controls were analyzed by reverse transcription-polymerase chain reaction (RT-PCR) based on single strand conformation polymorphism (SSCP) and sequencing. RT-PCR showed that all samples expressed HCP gene, only one missense mutation at codon 225 (AAC to AGC, Asn to Ser) within N-terminal SH2 domain was found in an ALL patient. In addition, four polymorphic base substitutions were detected in codon 69, 85, 86 and 266, respectively. In conclusion, mutation of HCP gene is an infrequent genetic aberration which may only play a role in pathogenesis of a small part of leukemia, however, its significance needs to be further clarified.
Full text:
1
Database:
WPRIM
Main subject:
Leukemia
/
Acute Disease
/
Protein Tyrosine Phosphatases
/
Polymorphism, Single-Stranded Conformational
/
Cell Line, Tumor
/
Intracellular Signaling Peptides and Proteins
/
Protein Tyrosine Phosphatase, Non-Receptor Type 6
/
Genetics
/
Mutation
Limits:
Humans
Language:
En
Journal:
Journal of Experimental Hematology
Year:
2004
Document type:
Article